Bernard Côté Ph.D
Co-President, Drug Discovery
Co-founder of Giiant Pharma, Dr. Côté specializes in drug discovery and has led large Merck Frosst chemistry and multi-disciplinary teams who identified several anti-inflammatory clinical candidates and the once-a-day HIV drug doravirine.

Elizabeth Kwong Ph.D
Co-President, Drug Development
Co-founder of Giiant Pharma, Dr. Kwong specializes in drug development and has supported the formulation of over 100 pre-clinical candidates and several late-stage Merck candidates including: Singulair®, Arcoxia®, Belsomra® and odanacatib.